CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests.
AstraZeneca on ‘independent’ manufacturing; Samsung Bio’s next ADC deal
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. AstraZeneca CEO Pascal Soriot said